Thermo Fisher Scientific will utilise BenchSci's machine learning platform to mine antibody data published in peer-reviewed scientific journals. [ + ]

QUT research has shed fresh light on how head and neck cancer spreads to other organs, leading to the development of a simple blood test to predict patients' risk of spread. [ + ]

Scientists at Newcastle University, UK, have 3D-printed the first human corneas. [ + ]

The model places medical researchers in a much better position to develop more effective treatments for the third most common cause of cancer death worldwide. [ + ]

Scientists at a US-based hospital have identified the mechanism that determines how T cells specialise their development. [ + ]

If you thought stress was a solely human trait, you thought wrong. [ + ]

'Ivy' is a self-improving artificial intelligence system that continuously learns from the embryos it analyses. [ + ]

Medical device company BIOTRONIK has partnered with GenesisCare, the largest group of private practice cardiologists in Australia, to enhance outcomes for cardiac patients. [ + ]

Researchers have developed a new system that can detect and analyse molecules with very high precision and without needing bulky equipment. [ + ]

A new hybrid technique enhances the effectiveness of a special form of radiation therapy for cancer treatment. [ + ]

The risk is largely due to the use of more 'broad spectrum' antibiotics as alternatives to penicillin, which may be fuelling the development of drug-resistant bacteria. [ + ]

Researchers have discovered how to reverse drug resistance in head and neck squamous cell carcinoma — a type of cancer for which patient mortality remains stubbornly high. [ + ]

Melbourne scientists have taken a significant step towards developing a new vaccine for malaria with the help of cryo-EM (cryo-electron microscopy) technology. [ + ]

The prestigious NHMRC Research Excellence Awards recognise recent outstanding performance in the health and medical research field. [ + ]

Australian-listed Cann Group has secured the site for its proposed Stage 3 medicinal cannabis cultivation and GMP manufacturing facility. [ + ]